Short answer
REGENXBIO Inc. (RGNX) filed an 8-K current report with the SEC on August 25, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers). Gregory Ciongoli elected independent Class II director through 2029 annual meeting.
REGENXBIO Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- Gregory Ciongoli elected independent Class II director through 2029 annual meeting
- Audit Committee and Nominating and Corporate Governance Committee appointments
- $550,000 initial equity award, split 75% stock option and 25% RSUs
- $45,000 board retainer plus $15,000 combined committee retainers annually
- Jean Bennett and A.N. “Jerry” Karabelas resigned; both remain advisors through February 2027 unless extended
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other REGENXBIO Inc. 8-K filings
Get the next RGNX 8-K as it lands
Follow RGNX for push alerts, or ask the research agent what this filing means.